Chuyên gia Nhật Bản khuyến nghị dùng thuốc kháng virus của Merck
Ngày 24/12, một hội đồng thuộc Bộ Y tế Nhật Bản đã khuyến nghị cấp phép sử dụng thuốc kháng virus do hãng dược Merck & Co Inc (Mỹ) phát triển. Đây là một phần trong các kế hoạch của Thủ tướng Kishida Fumio dự định triển khai trong năm tới để điều trị cho các bệnh nhân COVID-19, trong bối cảnh những lo ngại ngày một gia tăng liên quan biến thể Omicron của virus SARS-CoV-2.
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
Bình luận
Xin vui lòng gõ tiếng Việt có dấu